Chuyên gia Nhật Bản khuyến nghị dùng thuốc kháng virus của Merck
Ngày 24/12, một hội đồng thuộc Bộ Y tế Nhật Bản đã khuyến nghị cấp phép sử dụng thuốc kháng virus do hãng dược Merck & Co Inc (Mỹ) phát triển. Đây là một phần trong các kế hoạch của Thủ tướng Kishida Fumio dự định triển khai trong năm tới để điều trị cho các bệnh nhân COVID-19, trong bối cảnh những lo ngại ngày một gia tăng liên quan biến thể Omicron của virus SARS-CoV-2.
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
Bình luận
Xin vui lòng gõ tiếng Việt có dấu